Clinical Trials Directory

Trials / Completed

CompletedNCT02318966

Glycosade v UCCS in the Dietary Management of Hepatic GSD

A Comparison of Glycosade® and Uncooked Cornstarch (UCCS) for the Dietary Management of Hepatic Glycogen Storage Diseases (GSD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Vitaflo International, Ltd · Industry
Sex
All
Age
2 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To compare efficacy of Glycosade® with uncooked corn starch (UCCS for the dietary management of hepatic glycogen storage diseases (GSD).

Detailed description

'Glyde' is a prospective, randomised, double-blind, crossover trial to compare the effects of two different starches used in the dietary management of GSD. The study will recruit 64 patients from six centres in the UK, USA, France and The Netherlands. The planned duration per participant is 2 years. Participants will be randomised into two equally sized groups: Arm A- Glycosade intake given first, followed by UCCS 1-6 weeks later Arm B- UCCS intake given first, followed by Glycosade 1-6 weeks later. The objective of this trial is to establish whether Glycosade® improves outcomes for patients with GSD compared to UCCS therapy by comparing the duration of normal blood sugars, lactate and ketone levels of patients with hepatic GSD (Types I, III, VI and IX) post equivalent intakes of UCCS and Glycosade®. The first part consists of two (blinded) 12 hour starch load tests administered randomly within a maximum 6 week period. Participants will be randomised to receive either UCCS or Glycosade® for the initial intervention period crossing over to the other product for the second intervention period (part 1). The second part (unblinded) is a 24 month open follow up whereby participant's will continue on the product considered most suitable by the clinician and patient.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMedical Food - Glycosadedouble blind randomised crossover of 2 starches - glycosade and UCCS

Timeline

Start date
2016-02-22
Primary completion
2020-08-14
Completion
2020-08-14
First posted
2014-12-17
Last updated
2024-02-16

Locations

6 sites across 4 countries: United States, France, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT02318966. Inclusion in this directory is not an endorsement.